– UK, Reading – ConvaTec Group PLC (LON: CTEC) today announced the appointment of Sharon O’Keefe to its Board as a Non-Executive Director effective from 1 March 2022.
“I am delighted to welcome Sharon to our Board. She has extensive executive-level experience in medical centre environments with deep insight into patient care quality, engagement and innovation. Sharon brings to the Board very relevant international, medical and patient-focused experience. We look forward to Sharon’s contribution to our Board discussions.” said Board Chairman, John McAdam.
Sharon will also join the Remuneration and Nomination committees.
The Company also announced that Non-Executive Director Rick Anderson is stepping down from the Board with effect from 3 March 2022.
About Sharon O’Keefe
From 2011 to 2020, Sharon was President and COO of U Chicago Medicine, the US nationally ranked medical center with a network of physicians and specialty clinics with 10,000 employees and operating revenue of over $2 billion.
Sharon has over 40 years of healthcare and executive experience, with a particular focus on quality, efficiency, and innovation to create high-performance healthcare organizations.
Sharon is a Non-Executive Director of Adtalem Global Education, a $1.1 billion global educational services company, and of Vocera Communications, a $200 million healthcare technology company. She was previously a Non-Executive Director of Aviv REIT, a healthcare real estate investment trust that was acquired by Omega Healthcare Investors in 2015.
Sharon has an M.S. in Nursing Administration from the Loyola University of Chicago, and a B.S. in Nursing from Northern Illinois University.
About ConvaTec Group PLC
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes, and reduced total cost of care.
For more information: https://www.convatecgroup.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
